Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline + ursodeoxycholic acid to prevent radiation-induced liver toxicity after HDR brachytherapy
2008-002985-70Phase 2Completed
- Sponsor
- University of Magdeburg
- Start
- Dec 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of pentoxifylline and ursodeoxycholic acid in radiation-induced liver disease (RILD) and hepatic metastasis (2 arms), sponsored by University of Magdeburg. Primary endpoint: Primary: HDR-brachytherapy isodose border of liver damage. Started Dec 2008; status: completed.
02
Drugs
pentoxifyllineursodeoxycholic acid
03
Conditions
radiation-induced liver disease (RILD)hepatic metastasis
Beyond the preview
Go deeper on 2008-002985-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002985-70.